bioXXmed AG (FRA:T5O)
Germany · Delayed Price · Currency is EUR 0.8100
+0.0400 (5.19%)
Last updated: Jul 15, 2026, 4:24 PM CET
bioXXmed AG Market Cap
bioXXmed AG has a market cap or net worth of €209.34 thousand as of July 15, 2026. Its market cap has decreased by -64.72% in one year.
Market Cap
209.34K
Enterprise Value
390.67K
Revenue
16.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.81
Market Cap Chart
Since December 13, 2006, bioXXmed AG's market cap has decreased from 16.12M to 209.34K, a decrease of -98.70%. That is a compound annual growth rate of -19.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 209.34K | 600.00% |
| Dec 30, 2025 | 29.91K | -95.56% |
| Dec 30, 2024 | 673.01K | -88.20% |
| Dec 30, 2022 | 5.70M | -69.02% |
| Dec 30, 2021 | 18.41M | -70.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 78.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.83M |
| Paion AG | 435.16K |
| co.don AG | 334.04K |
| MagForce AG | 91.72K |